Mint-Montelukast

Active ingredients

• Montelukast — 4 mg

Form and route

Tablet (Chewable) · Oral

Schedule

PRESCRIPTION

Authorised since

2013-10-17

Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.

• Singulair02243602Organon Canada Inc.Montelukast (Montelukast Sodium) 4 mgTablet (Chewable)
• Sandoz Montelukast02330385Sandoz Canada IncorporatedMontelukast (Montelukast Sodium) 4 mgTablet (Chewable)
• PMS-Montelukast02354977Pharmascience IncMontelukast (Montelukast Sodium) 4 mgTablet (Chewable)
• Teva-Montelukast02355507Teva Canada LimitedMontelukast (Montelukast Sodium) 4 mgTablet (Chewable)
• Sandoz Montelukast02358611Sandoz Canada IncorporatedMontelukast (Montelukast Sodium) 4 mgGranules
• Apo-Montelukast02377608Apotex IncMontelukast (Montelukast Sodium) 4 mgTablet (Chewable)
• Montelukast02379821Pro Doc LimiteeMontelukast (Montelukast Sodium) 4 mgTablet (Chewable)
• Montelukast02382458Sivem Pharmaceuticals ULCMontelukast (Montelukast Sodium) 4 mgTablet (Chewable)
• Auro-Montelukast Chewable Tablet02422867Auro Pharma IncMontelukast (Montelukast Sodium) 4 mgTablet (Chewable)
• Jamp Montelukast Chewable Tablets02514877Jamp Pharma CorporationMontelukast (Montelukast Sodium) 4 mgTablet (Chewable)

Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.

Anatomical main group

Respiratory system

ATC code

R03DC03

The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of R03DC03, see the WHO ATC/DDD Index.